NCT05486026View on ClinicalTrials.gov

Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 20, 2022

Primary Completion Date

December 29, 2022

Study Completion Date

January 2, 2023

Conditions
Osteo Arthritis Knee
Interventions
DRUG

Duloxetine 30 MG

patient in first group (case) will receive duloxetine tablet 30mg for two weeks then titrated up to duloxetine 30mg BID. Patients will be instructed to take the medication with meals. The for 13 weeks

DRUG

Nonsteroidal Antiinflammatory Drug

patient in this second group will receive NSAID for 3 weeks

Trial Locations (1)

44001

Rizgary and Cmc Hospital, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER